Journal Impact Factor 2.72**
Submit manuscript at www.longdom.org/submissions/pharmacovigilance.html or send as an e-mail attachment to the Editorial Office at [email protected]
Table of Contents
About the Journal
Index Copernicus Value 2016: 82.05
National Libray of Medicine [NLM ID] :101634347
The purpose of the Journal of Pharmacovigilance (JP) is to publish quality case reports, original research and review articles about the pharmaceutical intervention safety, side effects and adverse effects as well as medications toxicity. Unintended effects are common yet often times there is lack of qualitative and quantitative data that allows for an accurate assessment of the risk/benefits profile of pharmaceuticals. The Journal of Pharmacovigilance aims to fill this important knowledge gap.
Journal of Pharmacovigilance is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. The Journal of Pharmacovigilance is an open access peer-reviewed journal. Our full open-access policy, which makes all published material immediately available to the public and it is especially relevant when it comes to information about drugs safety and toxicity.
The Pharmacovigilance Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacovigilance journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacovigilance Open Access Journal are freely accessible to everyone immediately after publication.